Bleb survival for sequential multitreatment (MULT) regimen (d-mannose-6-phosphate at surgery, CTGF antibody injections on days 2 and 4, and Ilomastat on days 7, 12, and 20). Blebs receiving MULT survived an average of 29 days. Those treated with balanced saline solution, the negative control (CONT), survived an average of 17 days, and those treated with mitomycin-C (MMC) survived an average of 36 days.